LY6D: A new therapeutic target for Non-Alcoholic fatty liver disease
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP415377
下载链接
链接失效反馈官方服务：
资源简介：
Non-alcoholic fatty liver disease (NAFLD) is a serious metabolic disorder characterized by excess fat accumulation in the liver. We performed mouse liver transcriptome analysis and identified Lymphocyte Antigen 6 Family Member D (Ly6d) as a key regulator of hepatic steatosis and inflammatory response. Ly6d drives NAFLD progression by causing genetic and epigenetic changes. These findings point to Ly6d as a new therapeutic target for NAFLD.
创建时间：
2023-12-19
